We noticed that MTA2 was significantly upregulated in human pancreatic cancer tissues compared with that in non-cancer normal tissues (Fig. 1a and Supplementary Figure 1), and a higher expression level of MTA2 was associated with a shorter overall survival time (Fig. 1b). Here, MTA2 is linked to familial pancreatic carcinoma.